Miller Tabak Downgrades Mead Johnson Nutrition (MJN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Deutsche Bank Remains Optimistic on Mead Johnson (MJN) After Q4 Print, Boosts PT
February 1, 2013 11:41 AM ESTDeutsche Bank raised its price target on Mead Johnson Nutrition (NYSE: MJN) from $77 to $81 and affirmed its Buy rating following Q4 results.
The firm comments, "In the face of building pessimism in late 2012 and into 2013, we maintained an optimistic view on... More
Mead Johnson (MJN) Tops Q4 EPS by 4c, Gives FY13 Guidance
January 31, 2013 7:40 AM ESTMead Johnson Nutrition Co. (NYSE: MJN) reported Q4 EPS of $0.72, $0.04 better than the analyst estimate of $0.68. Revenue for the quarter came in at $981.1 million versus the consensus estimate of $953.84 million.
Mead Johnson Nutrition Co. sees FY2013 EPS of $3.22-3.30, versus the consensus of $3.33.... More
